EVEREST ORGANICS
Back to Cashflow Statement
|
EVEREST ORGANICS Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-5.38 Cr | ₹16 Cr | ₹18 Cr | ₹14 Cr | ₹14 Cr |
What is the latest Cash Flow from Operating Activities ratio of EVEREST ORGANICS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-5.38 Cr |
| Mar2024 | ₹16 Cr |
| Mar2023 | ₹18 Cr |
| Mar2022 | ₹14 Cr |
| Mar2021 | ₹14 Cr |
How is Cash Flow from Operating Activities of EVEREST ORGANICS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-5.38 Cr | Negative | |
| Mar2024 | ₹16 Cr | -12.61 | |
| Mar2023 | ₹18 Cr | 34.06 | |
| Mar2022 | ₹14 Cr | 1.51 | |
| Mar2021 | ₹14 Cr | - | |
Compare Cash Flow from Operating Activities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹322.8 Cr | 3.4% | 25.1% | -1.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.8% | 8.3% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7.1% | 9% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2% | 12.1% | 49.6% | Stock Analytics | |
| CIPLA | ₹115,477.0 Cr | -0.7% | 4.1% | -3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -1.7% | -4.2% | -3.1% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | 3.4% |
25.1% |
-1.5% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses